Literature DB >> 18060363

Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue.

Wolfgang K Pfisterer1, Stephen W Coons, Fahmy Aboul-Enein, William P Hendricks, Adrienne C Scheck, Mark C Preul.   

Abstract

The fluorescence in situ hybridization (FISH) technique was used in 111 WHO grades I and II meningioma patients. Clinical, radiological, pathological, and immunohistochemical data were compared to aberrations of chromosomes 1p, 14q, and 22q determined by FISH. Significant differences for MIB-1 labeling were found between grades I and II tumors (p < 0.001), and between grade I tumors that recurred and those that did not recur (p < 0.001). Chromosomal aberrations were detected with FISH analysis in nearly 50% of grade I, and in 93% of grade II meningiomas. The numbers of chromosomal aberrations correlated significantly to MIB-1 (p < 0.001), with signs of grossly invasive tumor growth (p < 0.001), and with tumor recurrence (p < 0.01). The findings suggest that adding FISH analysis may allow better prediction of possible meningioma recurrence and may be a useful adjunct for therapy decisions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060363     DOI: 10.1007/s11060-007-9498-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  35 in total

1.  Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas.

Authors:  P Leuraud; Y Marie; E Robin; S Huguet; J He; K Mokhtari; P Cornu; K Hoang-Xuan; M Sanson
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

2.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

3.  No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry.

Authors:  M L Møller; O Braendstrup
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

4.  The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms.

Authors:  Richard A Prayson
Journal:  Adv Anat Pathol       Date:  2005-05       Impact factor: 3.875

5.  Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.

Authors:  D X Cai; R Banerjee; B W Scheithauer; C M Lohse; B K Kleinschmidt-Demasters; A Perry
Journal:  J Neuropathol Exp Neurol       Date:  2001-06       Impact factor: 3.685

6.  Evaluation of relationship between chromosome 22 and p53 gene alterations and the subtype of meningiomas by the interphase-FISH technique.

Authors:  Tahsin Yakut; Ahmet Bekar; Muammer Doygun; Hasan Acar; Unal Egeli; Erhan Ogul
Journal:  Teratog Carcinog Mutagen       Date:  2002

7.  Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.

Authors:  K Ueki; C Wen-Bin; Y Narita; A Asai; T Kirino
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

8.  Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor.

Authors:  M Bitzer; H Opitz; J Popp; M Morgalla; A Gruber; E Heiss; K Voigt
Journal:  Acta Neurochir (Wien)       Date:  1998       Impact factor: 2.216

9.  Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas?

Authors:  Wolfgang K Pfisterer; William P Hendricks; Adrienne C Scheck; Ronald A Nieman; Thomas H Birkner; Wolfgang W Krampla; Mark C Preul
Journal:  Neurosurgery       Date:  2007-11       Impact factor: 4.654

Review 10.  Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture.

Authors:  C B Wilson
Journal:  J Neurosurg       Date:  1994-11       Impact factor: 5.115

View more
  5 in total

1.  Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression.

Authors:  Xun Zhang; Roger Gejman; Ali Mahta; Ying Zhong; Kimberley A Rice; Yunli Zhou; Pornsuk Cheunsuchon; David N Louis; Anne Klibanski
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

Review 2.  Pathological classification and molecular genetics of meningiomas.

Authors:  Christian Mawrin; Arie Perry
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

3.  Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype.

Authors:  Patrícia Henriques Domingues; Pablo Sousa; Álvaro Otero; Jesus Maria Gonçalves; Laura Ruiz; Catarina de Oliveira; Maria Celeste Lopes; Alberto Orfao; Maria Dolores Tabernero
Journal:  Neuro Oncol       Date:  2014-02-16       Impact factor: 12.300

4.  Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma.

Authors:  Eva Serna; José Manuel Morales; Manuel Mata; José Gonzalez-Darder; Teresa San Miguel; Rosario Gil-Benso; Concha Lopez-Gines; Miguel Cerda-Nicolas; Daniel Monleon
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

5.  Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application.

Authors:  Cornelia Lerner; Ralf Ketter; Stefan Linsler; Wolfram Henn; Joachim Oertel; Steffi Urbschat
Journal:  Mol Cytogenet       Date:  2014-02-05       Impact factor: 2.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.